Advances in fecal microbiota transplantation for the treatment of diabetes mellitus

Diabetes mellitus (DM) refers to a group of chronic diseases with global prevalence, characterized by persistent hyperglycemia resulting from various etiologies. DM can harm various organ systems and lead to acute or chronic complications, which severely endanger human well-being. Traditional treatm...

Full description

Bibliographic Details
Main Authors: Juan Zhang, Honggang Wang, Ying Liu, Min Shi, Minna Zhang, Hong Zhang, Juan Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1370999/full
_version_ 1797215854427897856
author Juan Zhang
Honggang Wang
Ying Liu
Min Shi
Minna Zhang
Hong Zhang
Juan Chen
author_facet Juan Zhang
Honggang Wang
Ying Liu
Min Shi
Minna Zhang
Hong Zhang
Juan Chen
author_sort Juan Zhang
collection DOAJ
description Diabetes mellitus (DM) refers to a group of chronic diseases with global prevalence, characterized by persistent hyperglycemia resulting from various etiologies. DM can harm various organ systems and lead to acute or chronic complications, which severely endanger human well-being. Traditional treatment mainly involves controlling blood sugar levels through replacement therapy with drugs and insulin; however, some patients still find a satisfactory curative effect difficult to achieve. Extensive research has demonstrated a close correlation between enteric dysbacteriosis and the pathogenesis of various types of DM, paving the way for novel therapeutic approaches targeting the gut microbiota to manage DM. Fecal microbiota transplantation (FMT), a method for re-establishing the intestinal microbiome balance, offers new possibilities for treating diabetes. This article provides a comprehensive review of the correlation between DM and the gut microbiota, as well as the current advancements in FMT treatment for DM, using FMT as an illustrative example. This study aims to offer novel perspectives and establish a theoretical foundation for the clinical diagnosis and management of DM.
first_indexed 2024-04-24T11:36:41Z
format Article
id doaj.art-d5af1613064b461ab487870634131d49
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-24T11:36:41Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-d5af1613064b461ab487870634131d492024-04-10T05:09:33ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882024-04-011410.3389/fcimb.2024.13709991370999Advances in fecal microbiota transplantation for the treatment of diabetes mellitusJuan Zhang0Honggang Wang1Ying Liu2Min Shi3Minna Zhang4Hong Zhang5Juan Chen6Department of Endocrinology, the Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, ChinaDepartment of Gastroenterology, the Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, ChinaDepartment of Endocrinology, the Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, ChinaDepartment of Endocrinology, the Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, ChinaDepartment of Gastroenterology, the Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, ChinaDepartment of Endocrinology, the Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, ChinaDepartment of Endocrinology, the Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, ChinaDiabetes mellitus (DM) refers to a group of chronic diseases with global prevalence, characterized by persistent hyperglycemia resulting from various etiologies. DM can harm various organ systems and lead to acute or chronic complications, which severely endanger human well-being. Traditional treatment mainly involves controlling blood sugar levels through replacement therapy with drugs and insulin; however, some patients still find a satisfactory curative effect difficult to achieve. Extensive research has demonstrated a close correlation between enteric dysbacteriosis and the pathogenesis of various types of DM, paving the way for novel therapeutic approaches targeting the gut microbiota to manage DM. Fecal microbiota transplantation (FMT), a method for re-establishing the intestinal microbiome balance, offers new possibilities for treating diabetes. This article provides a comprehensive review of the correlation between DM and the gut microbiota, as well as the current advancements in FMT treatment for DM, using FMT as an illustrative example. This study aims to offer novel perspectives and establish a theoretical foundation for the clinical diagnosis and management of DM.https://www.frontiersin.org/articles/10.3389/fcimb.2024.1370999/fullfecal microbiota transplantationdiabetes mellitusdiabetes complicationsgastrointestinal microbiomemetabolitemetabolic disease
spellingShingle Juan Zhang
Honggang Wang
Ying Liu
Min Shi
Minna Zhang
Hong Zhang
Juan Chen
Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
Frontiers in Cellular and Infection Microbiology
fecal microbiota transplantation
diabetes mellitus
diabetes complications
gastrointestinal microbiome
metabolite
metabolic disease
title Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
title_full Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
title_fullStr Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
title_full_unstemmed Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
title_short Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
title_sort advances in fecal microbiota transplantation for the treatment of diabetes mellitus
topic fecal microbiota transplantation
diabetes mellitus
diabetes complications
gastrointestinal microbiome
metabolite
metabolic disease
url https://www.frontiersin.org/articles/10.3389/fcimb.2024.1370999/full
work_keys_str_mv AT juanzhang advancesinfecalmicrobiotatransplantationforthetreatmentofdiabetesmellitus
AT honggangwang advancesinfecalmicrobiotatransplantationforthetreatmentofdiabetesmellitus
AT yingliu advancesinfecalmicrobiotatransplantationforthetreatmentofdiabetesmellitus
AT minshi advancesinfecalmicrobiotatransplantationforthetreatmentofdiabetesmellitus
AT minnazhang advancesinfecalmicrobiotatransplantationforthetreatmentofdiabetesmellitus
AT hongzhang advancesinfecalmicrobiotatransplantationforthetreatmentofdiabetesmellitus
AT juanchen advancesinfecalmicrobiotatransplantationforthetreatmentofdiabetesmellitus